Rethinking ovarian cancer II

Reducing mortality from high-grade serous ovarian cancer

David D. Bowtell, Steffen Böhm, Ahmed A. Ahmed, Paul Joseph Aspuria, Robert C. Bast, Valerie Beral, Jonathan S. Berek, Michael J. Birrer, Sarah Blagden, Michael A. Bookman, James D. Brenton, Katherine B. Chiappinelli, Filipe Correia Martins, George Coukos, Ronny Drapkin, Richard Edmondson, Christina Fotopoulou, Hani Gabra, Jérôme Galon, Charlie Gourley & 21 others Valerie Heong, David G. Huntsman, Marcin Iwanicki, Beth Y. Karlan, Allyson Kaye, Ernst Lengyel, Douglas A. Levine, Karen H. Lu, Iain A. McNeish, Usha Menon, Steven A. Narod, Brad H. Nelson, Kenneth Nephew, Paul Pharoah, Daniel J. Powell, Pilar Ramos, Iris L. Romero, Clare L. Scott, Anil K. Sood, Euan A. Stronach, Frances R. Balkwill

Research output: Contribution to journalArticle

238 Citations (Scopus)

Abstract

High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.

Original languageEnglish (US)
Pages (from-to)668-679
Number of pages12
JournalNature Reviews Cancer
Volume15
Issue number11
DOIs
StatePublished - Oct 23 2015

Fingerprint

Ovarian Neoplasms
Mortality
Survival
Incidence
Research

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Bowtell, D. D., Böhm, S., Ahmed, A. A., Aspuria, P. J., Bast, R. C., Beral, V., ... Balkwill, F. R. (2015). Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer. Nature Reviews Cancer, 15(11), 668-679. https://doi.org/10.1038/nrc4019

Rethinking ovarian cancer II : Reducing mortality from high-grade serous ovarian cancer. / Bowtell, David D.; Böhm, Steffen; Ahmed, Ahmed A.; Aspuria, Paul Joseph; Bast, Robert C.; Beral, Valerie; Berek, Jonathan S.; Birrer, Michael J.; Blagden, Sarah; Bookman, Michael A.; Brenton, James D.; Chiappinelli, Katherine B.; Martins, Filipe Correia; Coukos, George; Drapkin, Ronny; Edmondson, Richard; Fotopoulou, Christina; Gabra, Hani; Galon, Jérôme; Gourley, Charlie; Heong, Valerie; Huntsman, David G.; Iwanicki, Marcin; Karlan, Beth Y.; Kaye, Allyson; Lengyel, Ernst; Levine, Douglas A.; Lu, Karen H.; McNeish, Iain A.; Menon, Usha; Narod, Steven A.; Nelson, Brad H.; Nephew, Kenneth; Pharoah, Paul; Powell, Daniel J.; Ramos, Pilar; Romero, Iris L.; Scott, Clare L.; Sood, Anil K.; Stronach, Euan A.; Balkwill, Frances R.

In: Nature Reviews Cancer, Vol. 15, No. 11, 23.10.2015, p. 668-679.

Research output: Contribution to journalArticle

Bowtell, DD, Böhm, S, Ahmed, AA, Aspuria, PJ, Bast, RC, Beral, V, Berek, JS, Birrer, MJ, Blagden, S, Bookman, MA, Brenton, JD, Chiappinelli, KB, Martins, FC, Coukos, G, Drapkin, R, Edmondson, R, Fotopoulou, C, Gabra, H, Galon, J, Gourley, C, Heong, V, Huntsman, DG, Iwanicki, M, Karlan, BY, Kaye, A, Lengyel, E, Levine, DA, Lu, KH, McNeish, IA, Menon, U, Narod, SA, Nelson, BH, Nephew, K, Pharoah, P, Powell, DJ, Ramos, P, Romero, IL, Scott, CL, Sood, AK, Stronach, EA & Balkwill, FR 2015, 'Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer', Nature Reviews Cancer, vol. 15, no. 11, pp. 668-679. https://doi.org/10.1038/nrc4019
Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ, Bast RC, Beral V et al. Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer. Nature Reviews Cancer. 2015 Oct 23;15(11):668-679. https://doi.org/10.1038/nrc4019
Bowtell, David D. ; Böhm, Steffen ; Ahmed, Ahmed A. ; Aspuria, Paul Joseph ; Bast, Robert C. ; Beral, Valerie ; Berek, Jonathan S. ; Birrer, Michael J. ; Blagden, Sarah ; Bookman, Michael A. ; Brenton, James D. ; Chiappinelli, Katherine B. ; Martins, Filipe Correia ; Coukos, George ; Drapkin, Ronny ; Edmondson, Richard ; Fotopoulou, Christina ; Gabra, Hani ; Galon, Jérôme ; Gourley, Charlie ; Heong, Valerie ; Huntsman, David G. ; Iwanicki, Marcin ; Karlan, Beth Y. ; Kaye, Allyson ; Lengyel, Ernst ; Levine, Douglas A. ; Lu, Karen H. ; McNeish, Iain A. ; Menon, Usha ; Narod, Steven A. ; Nelson, Brad H. ; Nephew, Kenneth ; Pharoah, Paul ; Powell, Daniel J. ; Ramos, Pilar ; Romero, Iris L. ; Scott, Clare L. ; Sood, Anil K. ; Stronach, Euan A. ; Balkwill, Frances R. / Rethinking ovarian cancer II : Reducing mortality from high-grade serous ovarian cancer. In: Nature Reviews Cancer. 2015 ; Vol. 15, No. 11. pp. 668-679.
@article{3d27c0e528094e0fa17f9eebcbd1fc92,
title = "Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer",
abstract = "High-grade serous ovarian cancer (HGSOC) accounts for 70-80{\%} of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.",
author = "Bowtell, {David D.} and Steffen B{\"o}hm and Ahmed, {Ahmed A.} and Aspuria, {Paul Joseph} and Bast, {Robert C.} and Valerie Beral and Berek, {Jonathan S.} and Birrer, {Michael J.} and Sarah Blagden and Bookman, {Michael A.} and Brenton, {James D.} and Chiappinelli, {Katherine B.} and Martins, {Filipe Correia} and George Coukos and Ronny Drapkin and Richard Edmondson and Christina Fotopoulou and Hani Gabra and J{\'e}r{\^o}me Galon and Charlie Gourley and Valerie Heong and Huntsman, {David G.} and Marcin Iwanicki and Karlan, {Beth Y.} and Allyson Kaye and Ernst Lengyel and Levine, {Douglas A.} and Lu, {Karen H.} and McNeish, {Iain A.} and Usha Menon and Narod, {Steven A.} and Nelson, {Brad H.} and Kenneth Nephew and Paul Pharoah and Powell, {Daniel J.} and Pilar Ramos and Romero, {Iris L.} and Scott, {Clare L.} and Sood, {Anil K.} and Stronach, {Euan A.} and Balkwill, {Frances R.}",
year = "2015",
month = "10",
day = "23",
doi = "10.1038/nrc4019",
language = "English (US)",
volume = "15",
pages = "668--679",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Rethinking ovarian cancer II

T2 - Reducing mortality from high-grade serous ovarian cancer

AU - Bowtell, David D.

AU - Böhm, Steffen

AU - Ahmed, Ahmed A.

AU - Aspuria, Paul Joseph

AU - Bast, Robert C.

AU - Beral, Valerie

AU - Berek, Jonathan S.

AU - Birrer, Michael J.

AU - Blagden, Sarah

AU - Bookman, Michael A.

AU - Brenton, James D.

AU - Chiappinelli, Katherine B.

AU - Martins, Filipe Correia

AU - Coukos, George

AU - Drapkin, Ronny

AU - Edmondson, Richard

AU - Fotopoulou, Christina

AU - Gabra, Hani

AU - Galon, Jérôme

AU - Gourley, Charlie

AU - Heong, Valerie

AU - Huntsman, David G.

AU - Iwanicki, Marcin

AU - Karlan, Beth Y.

AU - Kaye, Allyson

AU - Lengyel, Ernst

AU - Levine, Douglas A.

AU - Lu, Karen H.

AU - McNeish, Iain A.

AU - Menon, Usha

AU - Narod, Steven A.

AU - Nelson, Brad H.

AU - Nephew, Kenneth

AU - Pharoah, Paul

AU - Powell, Daniel J.

AU - Ramos, Pilar

AU - Romero, Iris L.

AU - Scott, Clare L.

AU - Sood, Anil K.

AU - Stronach, Euan A.

AU - Balkwill, Frances R.

PY - 2015/10/23

Y1 - 2015/10/23

N2 - High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.

AB - High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.

UR - http://www.scopus.com/inward/record.url?scp=84944871061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944871061&partnerID=8YFLogxK

U2 - 10.1038/nrc4019

DO - 10.1038/nrc4019

M3 - Article

VL - 15

SP - 668

EP - 679

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 11

ER -